Email
Print
Natamycin Market Overview
Natamycin Market size is $68.5M in 2019, growing at a CAGR of 3.3% during the forecast period 2020-2025. Natamycin also known as Pimaricin is a FDA approved drug used as an antifungal medication for conjunctiva tissue (eye), oral and skin infections. It is permitted to protect food preservatives such as cheese, fermented meat, yogurt, beverages, baked goods and others against yeasts and molds. It is used as a preservative for the food products to enhance the quality and increase the product self-life. It is an anti-fungal agent produced during aerobic fermentation by the Streptomyces natalensis, a bacterium in soil. It is odorless and colorless liquid to prevent fungal infections of the cell membrane from the food without affecting the products flavor. It is used as chemical preservatives owing towards its neutral taste or flavor impact and less pH dependence for efficacy.
Report Coverage
The report: “Natamycin Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Natamycin Market.
By Type: Lactose, Glucose, Others.
By Form: Liquid, Powder, Tablets, Capsules, Gel, Others.
By Application: Pharmaceutical Industry, Food & Beverage Industry, Healthcare Industry, Others.
By Geography: North America, Europe, Asia-Pacific, and Rest of the World
Key Takeaways
- Increase in demand for processed and advanced packaged foods and the increasing food safety regulations are set to propel the growth of the market.
- Stringent food safety regulation by governments on food and beverage products worldwide drives the market’s growth.
- The rising consumption of ready-to-eat meals and increased use in antifungal pharmaceutical products is driving the growth of market.
- Europe region is estimated to record the fastest growth rate during the forecast period 2020-2025.
By Application - Segment Analysis
In 2019, Food & Beverage Industry segment dominated the Natamycin Market in terms of revenue is estimated to grow at a CAGR of 2.9%. Natamycin is used as a preservative in baked goods, meat, fruit juice, wine, margarine, yogurt, dairy, vegetables, and fruits products. It binds to ergosterol a building block in the cell walls or membrane of yeasts and molds, for the preservation of food products. It requires prevention from fungal infections and the contamination of minerals and vitamins in the food & beverage products and health-conscious people can consume these for the same nutritional benefits aiding towards the market’s growth.
Geography - Segment Analysis
In 2019, the Asia-Pacific region dominated Natamycin Market in terms of revenue with a market share of 38% owing towards the increase in the food and beverage industries. This growth can be attributed to increasing growth of population and increased demand for dairy and meat products. China, Japan and India have technological advancements and increasing adoption of connected devices to promote the antifungal food preservations for the safety of goods products. Government has taken initiatives to promote technological advancements in this region are key factors in the growth of the Natamycin market. Europe is estimated to record the fastest growth rate during the forecast period 2020-2025.
Drivers – Natamycin Market
- Increase in The Product Safety and Self-Life
Increase of safety regulations by the Government for food industries drive the Natamycin Market owing towards the demand for organic, fresh, and exotic products with better quality. Consumers demand for high quality products with no changes in nutritional, mineral and calcium properties. Increasing deployment of food and packaging industries across the globe is other major factor driving growth of the Natamycin market. Presence of retail and e-commerce channels has also driven the market for goods product owing to their ease of availability and lower cost.
Challenges – Natamycin Market
- Stringent Government Regulation
The lack of proficient organization for Natamycin system and growing stringent government policy and regulation in the North America region of this drug for food preservation towards market growth is restraining growth of the market. Voriconazole is an alternative for Natamycin and is mostly preferred by healthcare sector as it gives clear vision.
Natamycin Industry Outlook
Product Launches was the key strategy of the players in the Natamycin Industry. Natamycin top 10 companies include Royal DSM N.V., Handary Amtech Biotech, Zhejiang Silver-Elephant Co. Ltd., Lanzhou Weiri, Langfang Meihua Bio-Technology KK Co. Ltd., Qingdao FTZ United International Inc., Chihon Biotechnology, VGP Pharmachem, JiaozuoJoincare and Beijing Oriental Rada Co., Ltd.
Acquisitions/Product Launches
- In December 2019, Royal DSM N.V, a global science-based company in Nutrition, Health and Sustainable Living acquired Royal CSK. This acquisition helped in strengthening DSM’s ability to serve the needs of dairy industries worldwide.
1. Natamycin Market Overview
1.1 Definitions and Scope
2. Natamycin Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Type
2.3 Key trends by Application
2.4 Key trends by Geography
3. Natamycin Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Natamycin Market - Startup Companies Scenario (Premium)
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Natamycin Market – Industry Market Entry Scenario Premium (Premium)
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Natamycin Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters Five Force Model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Natamycin Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Natamycin Market – By Type (Market Size –$Million/$Billion)
8.1 Lactose
8.2 Glucose
8.3 Others
9. Natamycin Market – By Form (Market Size –$Million/$Billion)
9.1 Liquid
9.2 Powder
9.3 Tablets
9.4 Capsules
9.5 Gel
9.6 Others
10. Natamycin Market – By Application (Market Size –$Million/$Billion)
10.1 Pharmaceutical Industry
10.2 Food & Beverage Industry
10.2.1 Bakery
10.2.2 Beverage Drinks
10.2.3 Dairy Products
10.2.4 Meat Products
10.2.5 Others
10.3 Healthcare Industry
10.4 Others
11. Natamycin Market - By Geography (Market Size –$Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Denmark
11.2.7 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Malaysia
11.3.7 Rest of Asia-Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Africa
11.4.3 South America
12. Natamycin Market - Entropy
13. Natamycin Market – Industry/Segment Competition Landscape (Premium)
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Countries – Key Companies
13.1.4 Best Practices for Companies
14. Natamycin Market – Key Company List by Country Premium (Premium)
15. Natamycin Market Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global Market Segmentation Market 2023-2030 ($M)1.1 By Application Market 2023-2030 ($M) - Global Industry Research
1.1.1 Bakery Market 2023-2030 ($M)
1.1.2 Meat and Poultry Market 2023-2030 ($M)
1.1.3 Dairy Market 2023-2030 ($M)
1.1.4 Beverage Market 2023-2030 ($M)
1.1.5 Oils and Fats Market 2023-2030 ($M)
2.Global Market Segmentation Market 2023-2030 (Volume/Units)
2.1 By Application Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Bakery Market 2023-2030 (Volume/Units)
2.1.2 Meat and Poultry Market 2023-2030 (Volume/Units)
2.1.3 Dairy Market 2023-2030 (Volume/Units)
2.1.4 Beverage Market 2023-2030 (Volume/Units)
2.1.5 Oils and Fats Market 2023-2030 (Volume/Units)
3.North America Market Segmentation Market 2023-2030 ($M)
3.1 By Application Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Bakery Market 2023-2030 ($M)
3.1.2 Meat and Poultry Market 2023-2030 ($M)
3.1.3 Dairy Market 2023-2030 ($M)
3.1.4 Beverage Market 2023-2030 ($M)
3.1.5 Oils and Fats Market 2023-2030 ($M)
4.South America Market Segmentation Market 2023-2030 ($M)
4.1 By Application Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Bakery Market 2023-2030 ($M)
4.1.2 Meat and Poultry Market 2023-2030 ($M)
4.1.3 Dairy Market 2023-2030 ($M)
4.1.4 Beverage Market 2023-2030 ($M)
4.1.5 Oils and Fats Market 2023-2030 ($M)
5.Europe Market Segmentation Market 2023-2030 ($M)
5.1 By Application Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Bakery Market 2023-2030 ($M)
5.1.2 Meat and Poultry Market 2023-2030 ($M)
5.1.3 Dairy Market 2023-2030 ($M)
5.1.4 Beverage Market 2023-2030 ($M)
5.1.5 Oils and Fats Market 2023-2030 ($M)
6.APAC Market Segmentation Market 2023-2030 ($M)
6.1 By Application Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Bakery Market 2023-2030 ($M)
6.1.2 Meat and Poultry Market 2023-2030 ($M)
6.1.3 Dairy Market 2023-2030 ($M)
6.1.4 Beverage Market 2023-2030 ($M)
6.1.5 Oils and Fats Market 2023-2030 ($M)
7.MENA Market Segmentation Market 2023-2030 ($M)
7.1 By Application Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Bakery Market 2023-2030 ($M)
7.1.2 Meat and Poultry Market 2023-2030 ($M)
7.1.3 Dairy Market 2023-2030 ($M)
7.1.4 Beverage Market 2023-2030 ($M)
7.1.5 Oils and Fats Market 2023-2030 ($M)
LIST OF FIGURES
1.US Global Natamycin Market Revenue, 2023-2030 ($M)2.Canada Global Natamycin Market Revenue, 2023-2030 ($M)
3.Mexico Global Natamycin Market Revenue, 2023-2030 ($M)
4.Brazil Global Natamycin Market Revenue, 2023-2030 ($M)
5.Argentina Global Natamycin Market Revenue, 2023-2030 ($M)
6.Peru Global Natamycin Market Revenue, 2023-2030 ($M)
7.Colombia Global Natamycin Market Revenue, 2023-2030 ($M)
8.Chile Global Natamycin Market Revenue, 2023-2030 ($M)
9.Rest of South America Global Natamycin Market Revenue, 2023-2030 ($M)
10.UK Global Natamycin Market Revenue, 2023-2030 ($M)
11.Germany Global Natamycin Market Revenue, 2023-2030 ($M)
12.France Global Natamycin Market Revenue, 2023-2030 ($M)
13.Italy Global Natamycin Market Revenue, 2023-2030 ($M)
14.Spain Global Natamycin Market Revenue, 2023-2030 ($M)
15.Rest of Europe Global Natamycin Market Revenue, 2023-2030 ($M)
16.China Global Natamycin Market Revenue, 2023-2030 ($M)
17.India Global Natamycin Market Revenue, 2023-2030 ($M)
18.Japan Global Natamycin Market Revenue, 2023-2030 ($M)
19.South Korea Global Natamycin Market Revenue, 2023-2030 ($M)
20.South Africa Global Natamycin Market Revenue, 2023-2030 ($M)
21.North America Global Natamycin By Application
22.South America Global Natamycin By Application
23.Europe Global Natamycin By Application
24.APAC Global Natamycin By Application
25.MENA Global Natamycin By Application
26.Danisco, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.DSM, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Handary, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Zhejiang Silver-Elephant, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Lanzhou Weiri, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Langfang Meihua, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Zhengzhou New Frey, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Chihon Biotechnology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Vgp Pharmachem, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.JiaozuoJoincare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Beijing Oriental Rada, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Pucheng Lifecome, Sales /Revenue, 2015-2018 ($Mn/$Bn)